Megan E V Caram (Megan V Caram)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 47

Top Topics

Benign Prostatic Hyperplasia

Radical Prostatectomy

Prostate Cancer

Top Venues

Cancer medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer 130 (18) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer 130 (18) (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Megan E V Caram, Kyle Kumbier, Phoebe A Tsao, Jennifer Burns, Jordan B Sparks, Kristian D Stensland, Zachery R Reichert, Joshi J Alumkal, Brent K Hollenbeck, Vahakn Shahinian, Alexander Tsodikov, Ted A Skolarus
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer. Cancer medicine 13 (12) (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer 130 (18) (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer 130 (18) (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer (2024)
Megan E V Caram, Kyle Kumbier, Phoebe A Tsao, Jennifer Burns, Jordan B Sparks, Kristian D Stensland, Zachery R Reichert, Joshi J Alumkal, Brent K Hollenbeck, Vahakn Shahinian, Alexander Tsodikov, Ted A Skolarus
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer. Cancer medicine 13 (12) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer (2024)
Charles B Nguyen, Christopher Kobe, Kyle E Kumbier, Jordan Bauman, Jennifer A Burns, Phoebe A Tsao, Jordan B Sparks, Ted A Skolarus, Megan E V Caram
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System. JCO oncology practice (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Phoebe A Tsao, Jennifer Burns, Kyle Kumbier, Jordan B Sparks, Shami Entenman, Lindsey E Bloor, Amy S B Bohnert, Ted A Skolarus, Megan E V Caram
Mental health care utilization among men with castration-resistant prostate cancer receiving abiraterone or enzalutamide. Cancer medicine (2023)
Megan E V Caram, Kyle Kumbier, Jennifer Burns, Jordan B Sparks, Phoebe A Tsao, Kristian D Stensland, Samuel L Washington, Brent K Hollenbeck, Vahakn Shahinian, Ted A Skolarus
Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system. Cancer medicine (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Nnenaya Agochukwu-Mmonu, Yongmei Qin, Samuel Kaufman, Mary Oerline, Randy A Vince, Danil Makarov, Megan E V Caram, Christina Chapman, Joseph Ravenell, Brent K Hollenbeck, Ted A Skolarus
Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. JCO oncology practice (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer (2023)
Daniel J Herr, David A Elliott, Gillian Duchesne, Kristian D Stensland, Megan E V Caram, Christina Hunter Chapman, Jennifer A Burns, Brent K Hollenbeck, Jordan B Sparks, Chris Shin, Alexander Zaslavsky, Alexander Tsodikov, Ted A Skolarus
Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system. Cancer (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Phoebe A Tsao, Jesse R Fann, Andrea L Nevedal, Lindsey E Bloor, Sarah L Krein, Megan E V Caram
A Positive Distress Screen…Now What? An Updated Call for Integrated Psychosocial Care. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Megan E V Caram, Kyle Kumbier, Jennifer Burns, Jordan B Sparks, Phoebe A Tsao, Kristian D Stensland, Samuel L Washington, Brent K Hollenbeck, Vahakn Shahinian, Ted A Skolarus
Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system. Cancer medicine (2023)
Lillian Y Lai, Samuel R Kaufman, Mary K Oerline, Megan E V Caram, Avinash Maganty, Brent K Hollenbeck, Vahakn B Shahinian
Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer. JNCI cancer spectrum 6 (2) (2022)
Lillian Y Lai, Mary K Oerline, Megan E V Caram, Phoebe A Tsao, Samuel R Kaufman, Brent K Hollenbeck, Vahakn B Shahinian
Risk of Metabolic and Cardiovascular Adverse Events With Abiraterone or Enzalutamide Among Men With Advanced Prostate Cancer. Journal of the National Cancer Institute 114 (8) (2022)
Megan E V Caram, Jennifer Burns, Kyle Kumbier, Jordan B Sparks, Phoebe A Tsao, Christina Hunter Chapman, Jordan Bauman, Brent K Hollenbeck, Vahakn B Shahinian, Ted A Skolarus
Factors influencing treatment of veterans with advanced prostate cancer. Cancer 127 (13) (2021)
Lillian Y Lai, Vahakn B Shahinian, Mary K Oerline, Samuel R Kaufman, Ted A Skolarus, Megan E V Caram, Brent K Hollenbeck
Understanding Active Surveillance for Prostate Cancer. JCO oncology practice 17 (11) (2021)
Cindy Y Jiang, Nadeem T El-Kouri, David Elliot, Jenna Shields, Megan E V Caram, Timothy L Frankel, Nithya Ramnath, Vida A Passero
Telehealth for Cancer Care in Veterans: Opportunities and Challenges Revealed by COVID. JCO oncology practice 17 (1) (2020)
Megan E V Caram, Mary K Oerline, Stacie B Dusetzina, Lindsey A Herrel, Parth K Modi, Samuel R Kaufman, Ted A Skolarus, Brent K Hollenbeck, Vahakn Shahinian
Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer 126 (23) (2020)
Christina Hunter Chapman, Megan E V Caram, Archana Radhakrishnan, Alexander Tsodikov, Curtiland Deville, Jennifer Burns, Alexander Zaslavsky, Michael Chang, John T Leppert, Timothy Hofer, Anne E Sales, Sarah T Hawley, Brent K Hollenbeck, Ted A Skolarus
Association between PSA values and surveillance quality after prostate cancer surgery. Cancer medicine 8 (18) (2019)